Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001965301-24-000070
Filing Date
2024-05-16
Accepted
2024-05-16 14:23:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2922
  Complete submission text file 0001965301-24-000070.txt   4729
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37891 | Film No.: 24954718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address KARL FARKAS GASSE 22 VIENNA C4 1030
Business Address KARL FARKAS GASSE 22 VIENNA C4 1030 0043 1 798 15 75 300
AFFIRIS AG in Liqu (Reporting) CIK: 0001876820 (see all company filings)

EIN.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 144